Politico June 7, 2024
THE LAB
The Pentagon is investigating how psychedelic medicine can help servicemembers — beyond mental health issues.
The agency has awarded $825,000 to Boston-based Delix Therapeutics for the development of a nonhallucinogenic version of the famed counterculture drug LSD to treat hearing loss.
Delix is among several pharmaceutical companies developing drugs that are structurally similar to psychedelics but without the characteristic high.
In the scientific world, psychedelics are known as neuroplastogens because of the way they can change connections in the brain.
Studies show that when hair cells inside the ear die, it leads to hearing loss. Early data shows that Delix’s compound can repair the connection between those cells and the fibers that send sound to the brain, reducing...
Today's Sponsors
Today's Sponsor